1. Home
  2. DAWN

DAWN

Day One Biopharmaceuticals Inc.

as 06-20-2025 3:34pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Founded: 2018 Country:
United States
United States
Employees: N/A City: BRISBANE
Market Cap: N/A IPO Year: 2021
Target Price: $31.57 AVG Volume (30 days): 1.2M
Analyst Decision: Strong Buy Number of Analysts: 7
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.71 EPS Growth: N/A
52 Week Low/High: $6.08 - $16.76 Next Earning Date: 07-29-2025
Revenue: $161,922,000 Revenue Growth: N/A
Revenue Growth (this year): 17.98% Revenue Growth (next year): 49.50%

DAWN Daily Stock ML Predictions

Stock Insider Trading Activity of Day One Biopharmaceuticals Inc. (DAWN)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Dubow Adam DAWN GENERAL COUNSEL May 15 '25 Sell $6.26 4,552 $28,485.96 47,136
Bender Jeremy DAWN CHIEF EXECUTIVE OFFICER May 15 '25 Sell $6.26 13,964 $87,385.32 145,737
Merendino Lauren DAWN Chief Commercial Officer May 15 '25 Sell $6.26 3,927 $24,574.77 35,161
York Charles N II DAWN COO, CFO AND SECRETARY May 15 '25 Sell $6.26 4,282 $26,796.33 265,231

Share on Social Networks: